Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4873378
Max Phase: Preclinical
Molecular Formula: C30H29ClF5N5O4
Molecular Weight: 654.04
Molecule Type: Unknown
Associated Items:
ID: ALA4873378
Max Phase: Preclinical
Molecular Formula: C30H29ClF5N5O4
Molecular Weight: 654.04
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(C[C@@H]1Cc2cc(Cl)c3c(c2CN(CC(F)(F)F)C1=O)C(F)(F)C(=O)N3)N1CCC(N2CCc3ccccc3NC2=O)CC1
Standard InChI: InChI=1S/C30H29ClF5N5O4/c31-21-12-17-11-18(26(43)40(15-29(32,33)34)14-20(17)24-25(21)38-27(44)30(24,35)36)13-23(42)39-8-6-19(7-9-39)41-10-5-16-3-1-2-4-22(16)37-28(41)45/h1-4,12,18-19H,5-11,13-15H2,(H,37,45)(H,38,44)/t18-/m0/s1
Standard InChI Key: SDVHRQIHKWUFFA-SFHVURJKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 654.04 | Molecular Weight (Monoisotopic): 653.1828 | AlogP: 4.92 | #Rotatable Bonds: 4 |
Polar Surface Area: 102.06 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.18 | CX Basic pKa: | CX LogP: 3.38 | CX LogD: 3.38 |
Aromatic Rings: 2 | Heavy Atoms: 45 | QED Weighted: 0.46 | Np Likeness Score: -0.38 |
1. Luo G, Jiang XJ, Chen L, Conway CM, Gulianello M, Kostich W, Keavy D, Signor LJ, Chen P, Davis C, Whiterock VJ, Schartman R, Widmann KA, Macor JE, Dubowchik GM.. (2021) Calcitonin gene-related peptide (CGRP) receptor antagonists: Heterocyclic modification of a novel azepinone lead., 43 [PMID:33932522] [10.1016/j.bmcl.2021.128077] |
Source(1):